Cardiac pacing techniques and equipment have developed dramatically in recent years. Bradycardias and tachycardias may be effectively treated by pacing. Bradyarrhythmias: It is generally accepted that pacing is indicated for a sustained symptomatic bradycardia. Prophylactic pacing for 'high-risk' bundle branch block in acute myocardial infarction is more controversial. A new era in cardiology has been introduced with the advent of 'physiological pacing', i.e. pacing of the heart with the maintenance of atrioventricular synchrony and varying the heart rate according to the body's metabolic leads. Modern pacing systems, which allow the atria and ventricles to contract in sequence, improve cardiac haemodynamics, result in subjective improvement and increase exercise tolerance. There are, however, pacemakerassociated and pacemaker-mediated tachyarrhythmias. Further advances in technology should overcome these problems. Tachyarrhythmias: Intracardiac electrocardiograms are often useful in the diagnosis of tachyarrhythmias, especially wide complex tachycardias. Rapid pacing of the atria in certain supraventricular tachycardias or of the ventricle in ventricular tachycardia is an alternative to cardioversion in many instances. This form of treatment is usually utilised in conjunction with drug therapy.
The heart can fail as a pump or it can fail electrically. Frequently, of course, the two are combined, e.g. a patient with acute myocardial infarction and cardiogenic shock may die in ventricular fibrillation. Electrical failure of the heart, be it bradyarrhythmia or tachyarrhythmia, may be treated by the delivery of electrical energy to the heart. I This can be done in a number of ways. 1. Cardiac pacing. The repetitive delivery of very low energies to the heart to initiate a cardiac impulse.
Transthoracic cardioversion or defibrillation
delivered through paddles placed on the chest wall in the classical manner (e.g. direct current shock for ventricular fibrillation).
This has been used successfully in the intensive care environment,3 although the method must still be regarded as experimental. 4. Ablation of a tachycardia circuit 4 ,5 by the delivery of up to 350 joules through a transvenous catheter. Usually, this is to the atrioventricular (AV) node in cases of recurrent supraventricular tachyarrhythmias resistant to medical therapy. This review is concerned mainly with temporary cardiac pacing as it relates to intensive care. Critical care patients sometimes have permanent pacemakers and thus an understanding of the different types of pacemakers, including their programmable functions, may be important in their management, e.g. in a patient admitted in hypovolaemic shock with a dual chamber permanent pacemaker in situ, a heart rate of only 72/minute and atria and ventricles not beating in sequence. It may be a simple matter to non-invasively change (i.e. program) the pacemaker to appropriately increase the heart rate and to sequentially pace atria and ventricles.
In the normal heart, pacemaker cells have the unique property of initiating and maintaining a rhythmic heartbeat. The sino-atrial (SA) node is usually the dominant pacemaker overriding all subsidiary escape pacemakers. The lower pacemakers are essentially emergency standby pacemakers should the SA node or some part of the conducting system, such as the atrioventricular (A-V) node, fail.
Artificial cardiac pacing is the repetitive delivery of very low electrical energies to the heart, thus initiating and maintaining the cardiac rhythm ( Figure 1 ). ------- 2. Permanent (internal): pulse generator is implanted. Pacing electrodes may be: 1. Unipolar. 2. Bipolar. Unipolar (Figure 2) The pacing lead has only one conducting wire and electrode. The electric current returns to the pacemaker via the body fluids. A unipolar lead is rarely used for temporary pacing because the skin electrode needed for the return current pathway may cause muscle twitching. Unipolar electrodes are commonly used for permanent pacing. Sensing of myopotentials (i.e. muscle) is a significant problem. 6, 7 p return pathway Bipolar (Figure 3 )
The lead has two conducting wires surrounded by a layer of insulation. The electric current travels down one wire to an electrode (usually the distal), passes through a part of the heart (causing it to depolarise), and returns to the pacemaker via the second electrode. This is virtually the only method used in Intensive Care/Coronary Care for temporary pacing. If one limb of the bipolar system fails, the remaining functioning limb may be converted to a unipolar system by connecting it to one pole (usually the positive) of the pacemaker and connecting a skin electrode to the other pole (usually negative).
Pacing sites 1. Transvenous endocardial: the pacing lead is manipulated via a vein to the endocardial surface of the heart, usually the right ventricle (Figure 1 Current pulse generators may not be suitable because a pulse width of 10 msec may be required. 13, 14 More studies are needed to evaluate this method, especially in the emergency setting. It has been suggested that, at least with atrial pacing,15 the depth of oesophageal insertion is important in minimising the pacing threshold. The prognosis of asystolic/bradycardiac cardiac arrest unresponsive to drug therapy is very poor and the outcome does not appear to be significantly improved by using any of the above techniques.
Pacing leads (Temporary transvenous)
There are many different types, sizes and shapes of leads, but basically in temporary pacing there are three types of leads: 1. Rigid (5) (6) (7) : The firm leads are fairly rigid but still flexible, and so can be manipulated under fluoroscopic control to a suitable position in the right ventricle (or coronary sinus). 2. ~emi-floating (4 French): These are fairly lImp and depend mainly on blood flow for positioning, although they can be manipulated to a certain extent. Flu,oroscopic control is not considered essential. An intracardiac ECG may be of assistance. In our Unit this lead is used mainly for rapid atrial pacing. 3. Balloon-tipped 16 (5) (6) ECGs are required for the diagnosis and treatment of a wide complex tachycardia. It is claimed that dual chamber pacing can be accomplished with this lead. In our experience it has not been reliable for dual chamber pacing.
Other leads are available, including a dual chamber single lead that is manipulated into the right ventricle. It has an atrial 'flare' attachment. Thus dual chamber pacing can be accomplished with only one lead.
Lead insertion
Virtually all pacemakers in our Intensive Care Unit are inserted percutaneously using a suitable percutaneous catheter introducer set. The introducer set should be of the same diameter as the pacing lead (e.g. a percutaneous catheter introducer set of 5 French will allow a 5 French pacing lead to be inserted). This applies to all sizes. Percutaneous insertion using the standard 'Seldinger' technique is the method of choice. Different veins can be used depending upon the expertise and experience of the operator. The right internal jugular vein approach probably has the lowest incidence of complications, together with easy manipulation and stability of the pacing lead. The infraclavicular subclavian vein is the route preferred by many experts, as it is best tolerated by patients and managed by nursing staff. Arm veins should be avoided as there is an increased incidence of lead instability l7 and thrombophlebitis is a problem. The femoral vein is best avoided, 18 unless the lead is only left in situ for a very short period, as deep vein thrombosis may result.
The pacing lead is manipulated under fluoroscopic control to the apex of the right ventricle (ventricular pacing), or coronary sinus/right atrial appendage (for atrial pacing). When a satisfactory position has been attained, the lead is attached to the external pulse generator, usually with the distal electrode connected to the negative pacemaker terminal. The stimulation threshold (i.e. the minimum amount of current required to consistently pace the heart) is measured. This ideally should be less than 1.0 mA, but certainly less than 2 mA (or 1.25V), with a pulse duration of 0.5 msec duration. The pacemaker output is then set at about 5 mA. Ideally, the sensing threshold (i.e. the minimum cardiac signal that the pacemaker senses) should also be measured. This is especially important in patients with acute myocardial infarction, hypokalaemia etc., where the threshold for ventricular fibrillation may be lowered. 19·21 It is essential in patients with inferior infarcts where, due to right ventricular involvement, the intracardiac R-wave may be very small and not sensed. This may lead to competition between spontaneous cardiac rhythm and the pacemaker, resulting in ventricular tachycardia (VT - Figure 4 ) or ventricular fibrillation (VF). A pacing systems analyser can be used to measure the size of the atrial or ventricular intracardiac signal sensed by the pacemaker. Complications of temporary transvenous pacemakers 17 -24 Pacing modes ( Figure 5 )
The 'three-position' identification code for pacemakers 25 has been generally accepted since its introduction in 1974. (b) T for triggered: the pacemaker produces an output after depolarisation is sensed. In single-chamber triggered pacing (i.e. AAT and VVT) the pacing impulse occurs immediately after sensing ( Figure 7 ) so that the pacing spike always falls in the absolute refractory period and therefore produces no cardiac response. The pacemaker, although it discharges with each spontaneous beat, captures the myocardium only when the intrinsic cardiac rate slows below the escape rate of the pulse generator. Use of three-position code is illustrated in Table 2 .
Five-position pacemaker code 26 . 27 Advances in pacing have necessitated expansion of the three-position code to five positions. Positions IV and V are relevant mainly to permanent pacing. Also in position -- III the letter R indicates reversal of function (i.e. the pacemaker is inhibited at slow rates and is activated by fast spontaneous rates). This function is used in the treatment of tachyarrhythmias. The five-position pacemaker code is summarised in Table 3 .
Position IV: describes programming functions P simple programming, one or two functions (usually rate and output). M multiprogrammability, including such features as mode, A-V delay, refractory period, sensitivity etc. 
Examples of new code
VVIP: paces ventricle, senses ventricular activity, ventricular activity inhibits (i.e. 'switches off') pacemaker, simple programmable (one or two functions). DVIM:
paces both atria and ventricles, ventricular sensing inhibits pacing output, multiprogrammable. DDDM: paces and senses both atria and ventricles in sequence, atrial Pacemaker is 'silent' during normal rhythm but if a supraventricular tachyarrhythmia is sensed, then there is rapid pacing of the atrium. It is non-programmable. Pacing of the atrium consists of rapid bursts of impulses. The three-position code is quite satisfactory to describe temporary pacing in the Intensive and Coronary Care Units, but the five-position code is useful to describe many permanent pacemakers in use today.
MODES OF PACING

Atrial and ventricular asynchronous pacing (AOO:VOO)
The pacemaker cannot sense any spontaneous cardiac rhythm. The heart is stimulated at a constant rate irrespective of the underlying rhythm. The pacemaker is called an asynchronous atrial pacemaker (AOO) if the electrodes are in the atrium, or an asynchronous ventricular pacemaker (VOO) if in the ventricle.
Asynchronous pacing ( Figure 8 ) is nowadays obsolete, except for the treatment of certain A trial demand pacing (AAI) Atrial demand pacing (AAI) is pacing the atrium and sensing spontaneous atrial activity ( Figure 9 ). The refractory period of the pacemaker (i.e. the period during which the pacemaker will not sense) must be long enough to prevent sensing of ventricular activity, otherwise ventricular activity could inhibit the pacemaker. The sensing system should be sensitive enough to detect atrial depolarisations which have small amplitudes. AAI pacing is indicated in situations where a bradycardia is associated with normal A-V conduction. Atria and ventricles will beat in sequence and this is haemodynamically desirable.
Ventricuiar demand pacing (VVI)
Ventricular demand pacing ( Figure 10 ) is by far the most commonly used mode. It is the Ventricular pacing with the loss of AV synchrony has an adverse effect on haemodynamics and this is more significant with sick hearts than with healthy hearts. This 'Pacemaker Syndrome' has been well documented. 29 It can be 'cured' by changing the mode of pacing to one more suited to the physiological needs of the patient.
VVI pacing is indicated if there is atrial fibrillation or flutter with AV block and a slow ventricular escape rate or in situations where 'standby' pacing only is required.
A trial synchronous ventricular pacing (VAT)
The atrial synchronous ventricular pacemaker (VAT - Figure 11 ) paces only the ventricle and senses only in the atrium. 'Atrial synchronous' means an atrial sense triggers ventricular pacing. When the pacemaker senses atrial activity, an AV timing circuit comes into operation and there is a delay between the atrial sense and the ventricular pace, producing an artificial PR interval. There may be problems sensing atrial activity ( Figure 11 ).
This mode of pacing maintains sinus control over the ventricular rate so that the atria and ventricles beat in sequence. With high atrial pacing. Representative ECG with competitive stimuli in beats 2 and 7 where ventricular activity has been sensed in the atrium as a 'P-wave'. This results in pacing on the T-wave after the preset A-V delay.
Anaesthesia and Intensive Care, Vol. 13, No. 1, February, 1985 rates (e.g. atrial fibrillation, paroxysmal supraventricular tachycardia etc.) the pacemaker will not pace the ventricle faster than its upper rate limiter. Thus, the pacemaker will not track atrial rates above a certain level and therefore the ventricle will be protected from too rapid rates. If there is a sinus bradycardia, the pacemaker reverts to VOO (i.e. asynchronous ventricular) at a predetermined backup rate.
If retrograde conduction from ventricle to atrium (V to A) occurs in a patient with an atrial synchronous pacemaker (V AT, VDD, DDD), the atrial signal may be sensed, provided it takes place outside the atrial-sensing refractory period. A ventricular stimulus will be delivered after the AV delay and should there be retrograde conduction of this to the atrium via the AV node, there will be an artificial accessory pathway in which the pacemaker is
Pacemaker type
Generic codes the anterograde pathway and the AV node is the retrograde pathway of the re-entry circuit. A trial synchronous ventricular inhibited pacing (VDD) Atrial synchronous ventricular inhibited is basically VAT plus VVI pacing ( Figure 12 ). There is pacing of the ventricle, sensing of both atrial and ventricular activity, and it works in both the triggered and inhibited modes. Therefore it can also be called a VDT 1I (i.e. atrial synchronous ventricular inhibited pacing).
The VDD pacemaker still does not pace the atrium but it can sense and pace the ventricle. Its advantage over V AT pacing is that with a sinus bradycardia the VDD pacemaker paces in the VVI (ventricular demand) mode, unlike the V AT pacemaker which will pace in the VOO (ventricular asynchronous) mode.
VDD pacing is indicated if there is a normal Representative ECG There is complete inhibition of pacing in the first beat because ventricular activity is sensed early enough to inhibit both atrial and ventricular pacing. In the second beat, no ventricular activity is apparent and pacing of atria and ventricles takes place in sequence. In the third beat, atrial pacing occurs and because it is conducted normally with depolarisation of the ventricle, the ventricular output of the pacemaker is inhibited. The fourth beat shows competition between the pacemaker and spontaneous atrial rhythm (i.e. non-sensing), but the R-wave is sensed and inhibits ventricular pacing. sinus rhythm with impaired A V conduction. As with VAT there may be problems associated with atrial tachyarrhythmias or if there is retrograde V to A conduction after ventricular premature beats. To prevent atrial tachyarrhythmias from causing pacemakerinduced ventricular tachyarrhythmias, rate limiters are an integral part of the VDD systems.
A V sequential pacing (DVI) This mode paces both atrium and ventricle in sequence (Figure 13 ). After a stimulus is delivered to the atrium there is a delay (the A-V delay) of about 150 msec, during which the impulse is either conducted to the ventricles by the usual pathway or, failing that, a ventricular pace is delivered. The advantage of this type of pacemaker is that atria and ventricles usually contract in sequence. There is, however, no atrial sensing and thus for A-V synchrony to be maintained the pacing atrial rate must be faster than the spontaneous atrial rate. In the Intensive Care/Coronary Care situation this is no great problem, as one can manually increase the pacemaker rate ( Figure 13 ). Two sets of electrodes are required atrial and ventricular.
DVI is basically VVI with atrial pacing, which is activated shortly before ventricular pacing ( Figure 14 ). DVI pacing is indicated when there is an atrial bradycardia, especially if associated with impaired A-V conduction. It is of no use if there are atrial tachyarrhythmias (e.g. atrial fibrillation). It should be emphasised that spontaneous atrial activity is not sensed, so there will be no change in cardiac rate in response to metabolic demands.
A-V universal pacing (DDD)
The A-V universal or optimal sequential . . pacemaker (DDD) paces and senses in both atrium and ventricle ( Figure 15 ). It may also be designated a DDTI/I. An atrial impulse will trigger (after a suitable delay) ventricular output while at the same time inhibiting an atrial output. If the impulse is conducted normally to the ventricle, then ventricular output is inhibited as with DVI. There are upper rate limiters to prevent the pacemaker from following too rapid atrial activity (e.g. atrial flutter) with paced atrial activity. The ventricular pace will be delivered every time the oscillator reaches zero. The R-R counter will be reset by a sensed or paced ventricular beat. When the R-R counter reaches NAV (the atrial trigger level) there will be an atrial pace. If spontaneous atrial activity occurs before NAV is reached then the atrial pace is inhibited. An atrial event (i.e. sensing or pacing) starts off an A-V counter which, when 'timed out', paces the ventricle. A ventricular event (i.e. pacing or spontaneous ventricular activity) resets the R-R counter. There is an atrial refractory period (i.e. period during which no atrial activity will be sensed) and a ventricular refractory period (i.e. period during which no ventricular activity will be sensed). There is an upper rate limiter.
DDD pacemaker wilh gradual increasing of Ihe alrial rale
BEA T 1: Atrial and ventricular pacing in sequence. BEAT 2: Atrial sensing with inhibition of atrial pacing, then ventricular pace after the A-V interval. BEAT 3: Atrial sensing with ventricular pacing with prolonged P-R interval (the A-V counter plus the upper rate timer results in an increased A-V delay). BEAT 4: The next P-wave is nOI sensed because it falls within the atrial refractory period of the pacemaker. BEAT 5: Atrial sensing and ventricular pacing with normal A-V delay. BEAT 6: Atrial activity not sensed and not conducted. BEAT 7: Atrial sense with ventricular pacing. Thus, with an increasing atrial rate, the pacemaker responds by increasing the P-R interval and then dropping beats (i.e. Wenckebach).
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The DDD pacemaker functions in different modes depending upon the underlying cardiac rhythm. (a) Atrial bradycardia with normal A-V conduction: atrial demand pacing (AA!).
(b) Normal sinus rhythm with high degree A-V block: atrial synchronous ventricular inhibited pacing (VDD). (c) Sinus bradycardia with A-V block: A-V sequential pacing (DVI). (d) Normal sinus rhythm with normal A-V conduction inhibits (i.e. switches off) both atrial and ventricular pacing.
pacemaker's low rate and A-V delay. Figure 16 illustrates how a DDD pacemaker, which features an upper rate limiter, will respond to a gradual increase in the spontaneous atrial rate.
Upper rate limiters are an important feature so that the pacemaker will not track atrial rates. It will depend on the spontaneous atrial rate and PR interval, compared with the The most frequent initiating event is retrograde conduction of a ventricular premature beat (Figure 17 ) to the atrium where it is sensed. Then after the A-V delay, ventricular pacing takes place again with retrograde V to A conduction. This then repeats itself endlessly. The rate of the tachycardia will fortunately be limited by the upper rate limiter of the pacemaker. This endless-loop tachycardia can only be provoked if the retrograde V to A conduction time exceeds that of the atrial refractory period of the pacemaker. With DDD or VDD pacemakers it is recommended that retrograde conduction from V to A is measured if present. The atrial refractory period of the pacemaker is then increased to 50 msec greater than the V to A conduction time. The presently available external temporary universal pacemaker provides a· variable atrial refractory period. However, should an endless-loop tachycardia occur this may be interrupted by inhibiting atrial sensing ( Figure 18 ). The tachycardia was broken by the application of a magnet which changed the mode to atrial and ventricular asynchronous (i.e. DOO) pacing.
Physiological pacing
This may be defined as pacing the heart while maintaining, in so far as possible, the normal activation sequence of the atria and ventricles and a physiological heart rate response similar to that of the normal SA node. There is no physiological pacemaker which is able to exactly adjust heart rate and the sequence of atrial and ventricular activation in response to all situations. 'Physiological pacing' is thus not exact. Dual chamber pacing has been shown in practice to improve measured haemodynamic parameters, exercise tolerance and the patient's subjective sense of well-being. Ventricular pacing (VVI) is consistently associated with a lower cardiac output, mean arterial pressure and higher left ventricular filling pressures than dual-chamber pacing. [38] [39] [40] [41] [42] [43] [44] [45] In the presence of high-degree A-V block there is an optimal A-V (i.e. PR) interval. 46, 47 Thus, the A-V interval may be manipulated to improve the haemodynamics, especially with temporary pacing in the Intensive Care or Coronary Care environment.
Atrial pacing has been shown to be of haemodynamic benefit in patients with right ventricular myocardial infarction, low cardiac output and a bradycardia. 48 ,49 There may be significant increase in cardiac output when atrial and ventricular pacing are compared at identical heart rates. FIGURE 18.-Endless-Ioop tachycardia. Ventricular pacing with retrograde conduction to the atrium, sensing of retrograde P which again is conducted to the atrium (beats I to 5). A magnet is applied to the pacemaker (000) which converts it to an asynchronous dual chamber mode (000). This 'breaks' the tachycardia circuit and atria and ventricles are paced in sequence at just over 80 beats per minute.
Anaesthesia and intensive Care, Vol. 13 Ventricular pacing with the loss of A-V synchrony has an adverse effect on haemodynamics and this is more marked with sick than healthy hearts. Physiological pacing should be considered in all suitable patients with pump failure in whom pacing is indicated. Unfortunately, physiological pacing usually requires two leads, one in the ventricle and the other either in the atrium or in the coronary sinus. Entering the coronary sinus can be difficult and time-consuming and temporary pacing from other sites has until fairly recently been unreliable. A new percutaneous atrial J-Iead has become available which makes FIGURE 19.-Programmer. Hand-held programmer which will change many pacing parameters, including mode, ventricular rate, A-V delay, ventricular maximal tracking rate, sensing ability, and atrial and ventricular refractory periods. positioning of the atrial pacing lead much easier and quicker. 50 
Programmability
Various parameters such as rate, current output, sensing ability, A-V interval, etc., may be changed quite simply in external pulse generators by turning the appropriate knob ( Figure 14) . Programming of permanent pacemakers is defined as the non-invasive alteration of various pacing parameters. A simple example is the placing of a magnet over the pulse generator to change a demand pacemaker to an asynchronous pacemaker ( Figure 18 ). (Figure 19 ) 
Programmable parameters
BRADYARRHYTHMIAS
The cardiac output is determined by the product of heart rate and stroke volume. The ability of the heart to acutely increase stroke volume is limited and so a fall in ventricular rate can result in a large decrease in cardiac output (Figure 20) . Cardiac pacing is indicated for any sustained symptomatic bradycardia of any origin not responding to medical treatment. Pacing may also be indicated if a bradycardia is demonstrated to predispose to malignant ventricular arrhythmias.
The most important aspect is not the specific bradycardia but whether or not there are symptoms of no or low cardiac output (e.g. syncope, hypotension, cardiac failure or angina).
For example, pacing is indicated in a patient with atrial fibrillation and a ventricular response of 50/min, associated with a blood pressure of 70/40 mmHg, cardiac failure and oliguria. Pacing is not indicated in an asymptomatic normotensive patient with an inferior myocardial infarction, complete heart block and a ventricular rate of 50/min.
The decision to pace is based on the presence of a bradycardia associated with haemodynamic deterioration and not on a specific rhythm disturbance.
Once the decision to pace has been made, then the appropriate mode of pacing should be decided on, depending on the underlying rhythm disturbance and the functional state of the myocardium (Le. whether or not 'pump' failure exists).
Acute myocardial infarction (AMI)
Acute myocardial infarction is somewhat different. Conduction defects following cardiac infarction may merit prophylactic pacing, although this is controversial. [51] [52] [53] [54] [55] Mobitz I A-V Block (Wenckebach block): increased PR intervals with dropped beats.
Mobitz 11 A-V Block: sudden development of second degree block with no preceding increase in the PR interval.
High-degree A-V block refers to type 11 second degree A-V block (e.g. 2:1) or third degree (complete) A-V block which is preceded by type 11 block or which develops suddenly. High-degree A-V block does not include type I second degree block (i.e. Wenckebach) or third degree block preceded by type I second degree A-V block.
Anterior and inferior infarcts have quite different characteristics ( Table 4 ).
The size of the cardiac infarct is the most important determinant of survival in patients Inferior myocardial infarction: Bradycardias are common and usually due to parasympathetic stimuli and reversible ischaemia of the S-A and A-V nodes. The prognosis is good and pacing is only indicated in the uncommon event of haemodynamic instability.
Anterior myocardial infarction: High-degree A-V block is often preceded by bundle branch block (BBB). Conduction disturbances are associated with large infarcts and hence the prognosis is dictated more by the size of the infarct than by the decision whether to pace or not. Pacing does, however, have a role, provided it can be done with mInimum complications, so that the benefits of pacing outweigh the risk.
Bundle branch block (BBB) during acute myocardial infarction: It is generally accepted that the intraventricular conduction system of the heart is trifascicular. (1) The right bundle branch constitutes one fascicle. (2) The left bundle branch is composed of the other two fascicles; (a) the anterior superior division and (b) a postero-inferior division. The anterior fascicle of the left bundle branch is close to the right bundle and it is more vulnerable than the posterior fascicle to pressure and ischaemic damage.
It has not been definitely established that prophylactic temporary pacing improves survival in patients with conduction blocks, but it is possible to predict mortality and progression to high-degree A-V block ( at high risk of developing high-degree A-V block and might benefit from prophylactic pacing (i.e. VVI). Hindman et al. 51.52 pointed out that of those patients who died in hospital about 9070 died suddenly from complete heart block in the absence of previous shock. Patients with Mobitz II second degree heart block or complete heart block had a higher hospital mortality than patients without heart block, even when pulmonary oedema or shock was not present. He also noted that of 102 patients who were prophylactically paced there was no incidence of sudden death or ventricular tachyarrhythmias during insertion. He concluded that temporary transvenous pacing is a safe procedure. Indications for pacing in AMl 1. Any sustained symptomatic bradycardia:
underlying cardiac rhythm will, of course, dictate the pacing mode. 2. High degree A-V block (i.e. second or third degree A-V block which has progressed via a Permanent prophylactic pacing may improve survival in post AMI patients whose course has been complicated by bundle branch block and transient high-degree A-V block. This remains controversial. 52.55 T ACHY ARRHYTHMIAS Tachyarrhythmias 56 ,58 can, and usually should, be treated by means other than temporary cardiac pacing. Many tachycardias, however, can be treated safely and effectively by pacing techniques alone or in combination with drugs. In certain instances, for example, after open heart surgery in which pacing electrodes are often routinely implanted in the atrial and ventricular epicardium, cardiac pacing, because of its immediate availability, may be the treatment of choice. With the obvious exceptions of ventricular fibrillation (VF), atrial fibrillation (AF), sinus tachycardia and type 11 atrial flutter (a regular atrial rhythm with an atrial rate greater than 340/min) virtually all tachyarrhythmias may be treated rapidly, effectively and safely with temporary cardiac pacing.
Suitable tachyarrythmias
These include: 1. Paroxysmal supraventricular tachycardias 2. Type I atrial flutter 3. Ventricular tachycardia (VT).
Cardiac pacing should be considered in any suitable tachyarrhythmia, especially if poorly tolerated haemodynamically.
Indications for pacing in tachyarrhythmias 1. (a) Drug therapy failure.
(b) Recurrent tachyarrhythmias.
2. Cardioversion contraindicated, e.g. digitalis intoxication, severe respiratory failure etc. 3. Diagnosis (i.e. to assist in diagnosis, especially in wide complex tachycardias).
Mechanism
The mechanism where pacing terminates a reentry tachycardia is best demonstrated in the Wolff-Parkinson-White model (Figure 21) . A The wave front passes in an anterograde manner from the right atrium to the right ventricle through the A-V node. It then passes back to the left atrium via the accessory pathway. B Pacing captures part of the tachycardia circuit but cannot break it. You need to get closer to the circuit or speed up the pacing rate. C At the faster rate, both limbs of the tachycardia are invaded. The wave front from the paced beat collides with the wave front from the tachycardia and they extinguish one another. From the practical point of view, this results in a block in the accessory pathway, and the re-entry tachycardia is now broken.
RAPID ATRIAL PACING (RAP)
Paroxysmal supraventricular tachycardia 59 -61 A pacing lead is placed in the right atrium or coronary sinus. The atrium is then paced (Figure 22 ) at a faster rate than that of the tachycardia. Pacing is started at a slow rate (e.g. 60-S0/min) with AOO (i.e. atrial asynchronous) pacing and increased slowly to above the spontaneous atrial rate (e.g. ISO/min). This should avoid inadvertent pacing The atrium is usually paced for about 30 seconds and then the pacemaker is switched off. Normal sinus rhythm should ensue ( Figure  23 ). If RAP does not result in conversion to normal sinus rhythm, the pacing catheter should be manipulated to different positions in the atrium and more rapid pacing rates attempted. If the tachycardia persists, atrial fibrillation is deliberately precipitated by RAP at 400-800/min. This is an unstable rhythm which usually reverts to normal sinus rhythm. Occasionally, atrial fibrillation persists, but even then the ventricular rate is usually slower and more responsive to drug therapy than the supraventricular tachycardia. Occasionally, it is necessary to continuously pace at 400-800/min to maintain the patient in atrial fibrillation until appropriate drug therapy permits chronic control of the tachycardia.
A trial flutter 58 ,62.63 The pacing lead is usually placed high in the right atrium. Atrial pacing is gradually increased until 10-20 beats faster than spontaneous atrial rhythm. The atrium can then be rapidly paced at a constant rate for periods of 20 to 30 seconds at increasing rates (i.e. 320, 330, 340, 350, 360/minute etc.) until the atrial complexes in the ECG lead A VF change from negative to positive. This indicates that the atrial flutter has been interrupted and so atrial pacing may be either abruptly terminated or slowed gradually to a desirable atrial rate. If pacing from the high right atrium changes the atrial complex in A VF from negative to positive, but does not convert the atrial flutter, this usually means that a minimally faster atrial rate is required to interrupt the atrial flutter. With rapid atrial pacing techniques, type I atrial flutter can nearly always be interrupted. The rhythm that evolves will usually be sinus rhythm, but atrial fibrillation or, rarely, type 11 atrial flutter may also develop. If atrial fibrillation persists, it is usually easier to treat in terms of control of the ventricular rate. In some patients in whom type I atrial flutter has been interrupted by RAP, the interruption will be transient. In such cases, especially when associated with a rapid ventricular response, it may be desirable to initiate and maintain rapid atrial pacing at a rate of approximately 450 beats/minute so that atrial fibrillation will be precipitated and sustained. In almost all instances this rapid, 13, No. I, February, 1985 (i) paroxysmal supraventricular tachycardia (ii) rapid atrial pacing with capture after 3-4 beats (iii) pacemaker switched off (iv) normal sinus rhythm. continuous pacing will permit easy, effective control of the ventricular response rate to this supraventricular rhythm because the ventricular response to atrial fibrillation is nearly always less than that of atrial flutter. Furthermore, if additional slowing of the ventricular response rate is clinically desirable, then digoxin, verapamil or beta-blockers may be used to control the ventricular rate by blocking conduction through the A-V node. RAP may be continued until drug therapy has had an opportunity to become effective and any transient factors contributing to the development and persistence of the arrhythmia have had time to dissipate. Failure to convert type I atrial flutter is usually associated with some reversible technical problem.
(a) Insufficiently rapid pacing rates: if you pace at a rate that is less than that required for interruption, the atrial flutter will simply be transiently entrained to the pacing rate without being interrupted. The critically rapid rate is most often 120-130070 of the spontaneous atrial flutter rate. (b) Insufficient duration of atrial pacing: it is suggested that RAP-selected rates be performed for at least 30 seconds or, if pacing from a site high in the right atrium, until the morphology of the atrial complexes in lead A VF become positive. (c) Insufficient stimulus strength: the stimulus strength to pace the atrium at rapid rates is often considerably higher than that required to obtain atrial capture when pacing the atria at a slower rate. The stimulus strength required to capture may occasionally be as high as 20 mA.
(d) Incorrect rhythm diagnosis: type 11 atrial flutter may be misdiagnosed as type I atrial flutter. There may even be some confusion with atrial fibrillation occasionally. Intracardiac recordings of a bipolar atrial electrocardiogram would demonstrate the characteristics of atrial fibrillation (i.e. marked variability of beat-to-beat cycle length, morphology, polarity and amplitude). (e) Loss of electrode contact with atrial tissue:
this is a common problem because if the pacing electrode is not in constant contact with the atria, pacing clearly will be ineffective.
Other potential technical problems include broken electrodes, pacemaker battery problems, inadequate contact between electrode and pacemaker etc.
Non-paroxysmal supraventricular tachycardias
Many of these arrhythmias will be noninterruptible by pacing. If the rhythm is associated with a rapid ventricular rate, then rapid atrial stimulation may still be indicated. The ventricular rate may be controlled by pacing the atrial at rates between 180-230 beats/minute to achieve 2: 1 A-V conduction which should result in ventricular rates between 90-115 beats/minute. Rapid ventricular pacing (Figure 24 )
There are several pacing techniques used to treat ventricular tachycardia (VT). These include: 1. Underdrive ventricular pacing. VOO pacing at rates less than that of the tachycardia. This may occasionally be successful ( Figure  25 ). 2. Overdrive atrial pacing. This may be of value provided there is 1: 1 A-V conduction. 3. Timed ventricular premature beat ( Figure  26 ). This is an effective method, but somewhat complex, especially in the intensive care environment. It is widely used in electrophysiological studies of ventricular tachycardia. 4. Ventricular burst pacing 64 (Figure 24 ). This is the method with which we have the most experience. It is simple and effective. Burst pacing is in many ways similar to RAP. Basically, the ventricle is paced at a rate that is about 120070 of the spontaneous ventricular tachycardia rate. This is done for 5-10 beats. The pacemaker is then switched off and hopefully normal sinus rhythm ensues ( Figure 27) . A special pacemaker is needed ( Figure 28 ) because the maximal pacing rate of the usual external pacing generators is only l50-l80/minute. Figure 29 ).
Precipitation of ventricular fibrillation (VF).
It is essential that trained personnel, a FIGURE 27.-Rapid ventricular pacing for ventricular tachycardia. Ventricular burst pacing with ventricular capture at about 260/minute by beat 7. When switched off, there is a run of a bizarre wide-complex tachycardia which is self-terminating and then sinus rhythm.
[.) FIGURE 29 .-Wide-complex tachycardia with ventricular burst pacing commenced at beat 3 and continued to beat 20. When pacing is stopped. there is a wide-complex tachycardia which is slightly faster than the previous tachycardia and has a different polarity.
defibrillator and appropriate drugs are immediately available when ventricular burst pacing is being undertaken.
The diagnosis of a wide-complex tachycardia
The surface electrocardiogram may show only a wide-complex tachycardia which could be either ventricular tachycardia or supraventricular tachycardia with aberrant conduction (i.e. rate dependent bundle branch block). An intracardiac ECG with electrodes in both the atrium and the ventricle may be of assistance ( Figure 30 ). If there is dissociation between the atria and the ventricles, then the rhythm is almost certainly ventricular tachycardia.
Advantages of pacing compared with direct current cardioversion 1. Diagnosis. Intracardiac ECG recording via the pacing lead can help in the diagnosis,
AVF VI
RA RV especially if the rhythm is a wide-complex tachycardia suspected of being ventricular in origin.
DC cardioversion contraindicated: pacing
can be used (albeit with caution) in patients on digoxin. 3. General anaesthetic is not needed: pacing is painless. 4. DC shock complications avoided, especially that of myocardial depression. 5. Repeated reversions: this is simple with cardiac pacing. 6. Standby pacing: if bradycardia or asystole develops after reversion, cardiac pacing is immediately available.
Pacing versus drug therapy
Most drugs used in the treatment of arrhythmias depress the heart. The use of pacing usually indicates failure of drug therapy FIGURE 30.-Wide-complex tachycardia with surface ECG leads (I. aVF. VI) and intracardiac ECGs from the right atrium (RA) and right ventricle (RV). The atria and the ventricles are beating independently. i.e. there is A-V dissociation. This is strongly in favour of the rhythm being ventricular tachycardia.
AnoeSlilesia and Intensive Care. Vol. 13, No. I, February, 1985 and so both modalities actually go hand In hand. 
